Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?

American Journal of Reproductive Immunology

Volumn 56, Issue 4, 2006, Pages 230-236

  Goodman, Cyle S ^a   Coulam, Carolyn B ^a,b,d   Jeyendran, Rajasingam S ^c   Acosta, Vida A ^c   Roussev, Roumen ^a  

^a Millenova Immunology Laboratories   (United States)

^b Rinehart Center for Reproductive Medicine   (United States)

^c Andrology Laboratory Services   (United States)

^d NONE   (United States)

Author keywords

Inherited thrombophilia; Recurrent pregnancy loss; Thrombophilic genes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBOCYTE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POINT MUTATION; PREGNANCY; RISK FACTORS; THROMBOPHILIA;

EID: 33747889879     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00419.x     Document Type: Article

References (47)

1. Hiller E, Pihusch R: Thrombophilia caused by congenital disorders of blood coagulation. Semin Thromb Hemost 1998; 116:26-32.
2. Sarto A, Rocha M, Martinez M, Pasqualini R: Hypofibrinolysis and other hemostatic defects in women with antecedents of early reproductive failure. Medicina 2000; 60:441-447.
3. Feng Q, Liu K, Liu YX, Bryne S, Ockleford CD: Plasminogen activators and inhibitors are transcribed during early macaque implantation. Placenta 2001; 22:186-189.
4. Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M: Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril 2001; 76:201-202.
5. Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I: Differences in the implantation rates of rat embryos developed in vivo and in vitro: possible role for plasminogen activators. Fertil Steril 2004; 81:780-785.
6. Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006; 55:360-368.
7. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA: Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 128:1000-1003.
8. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J, Kotsis A: Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15:458-462.
9. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M: Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43:31-35.
10. Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ: Thrombophilic gene mutations and recurrent spontaneous abortion: Prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001; 46:124-131.
11. Reznikoff-Etievan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J: Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 2001; 108:1251-1254.
12. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY: Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002; 71:300-305.
13. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB: Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
14. Gluek CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T: The 4G/5G of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications. Metabolism 2000; 49:845-852.
15. van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ: Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 2000; 107:785-791.
16. Grandone E, Margaglione M, Colaizzo D, Pavone G, Paladini D, Martinelli P, Di Minni G: Low birth-weight in neonates of mothers carrying factor V G1691A and factor A 20210 mutations. Haematologica 2002; 87:177-181.
17. Buchholz T, Thaler IJ: Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol 2003; 50:20-32.
18. Tranquilli AL, Giannubilo SR, Dell'uomo B, Grandone E: Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol 2004; 117:144-147.
19. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N: Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999; 82:6-9.
20. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B: Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002; 77:342-347.
21. Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online 2006; 12:322-327.
22. Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, Girolami A, Bernardi F: Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 2000; 96:1443-1448.
23. Ozcan T, Rinder HM, Murphy J, Kohn C, Copel JA: Genetic thrombophilia and thromboembolic complications. Am J Obstet Gynecol 2001; 184:S189.
24. Pasrinen T, Perola M, Niini P, Terwilliger J, Salomaa V, Varriainen E, Peltone L, Syvanen AC: Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 1998; 7:1453-1462.
25. Kohler HP, Futers TS, Grant PJ: Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Association with FXIII activity and antigen levels. Thromb Haemost 1999; 81:511-515.
26. Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ: Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 2002; 32:643-648.
27. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F, Cambien F: Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996; 93:440-449.
28. Eriksson P, Kallin B, van Hooft FM, Bavenholm P, Hamsten A: Allele-specific increase in basal transcription of the plasminogen-activator 1 gene is associated with myocardial infarction. PNAS 1995; 92:1851-1855.
29. Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM: 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998; 80:956-960.
30. Feng DL, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Meyers RH, Levy D, Tofler GH: Increased platelet aggregability associated with platelet GPIIIaP1 A 2 polymorphism. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19:1142-1147.
31. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG: Platelet glycoprotein IIb/IIIa homozygosity associated with risk of ischemic cardiovascular diseases and myocardial infarction in young men: The Copenhagen City Heart Study. J Am Coll Cardiol 2003; 42:661-667.
32. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64:169-172.
33. Wolf CE, Haubelt H, Pauer HU, Hinney B, Krome-Cesar C, Legler TJ, Hellstern P, Emons G, Zoll B, Kohler M: Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb 2003; 33:134-137.
34. Camilleri RS, Peebles D, Portmann C, Everington T, Cohen H: -455G/A b-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagul Fibrinolysis 2004; 15:139-147.
35. Hefler L, Jirecek S, Heim K, Grimm C, Antensteiner G, Zeillinger R, Husslein P, Tempfer C: Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: A multicenter study. J Soc Gynecol Invest 2004; 11:42-44.
36. Heng C-K, Lal S, Saha N, Low P-S, Kamboh MI: The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore. Hum Genet 2004; 114:186-191.
37. Infante-Rivard C, Rivard G-E, Yotov WV, Genin E, Guiguet M, Weinberg C, Gauthier R, Feoli-Fonseca JC: Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2005; 347:19-25.
38. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY: Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol 2005; 80:12-19.
39. Ruzzi L, Ciarafoni I, Silvestri L, Semeraro ML, Abeni D: Association of PLA2 polymorphism of the ITGB3 gene with early fetal loss. Fertil Steril 2005; 83:511-512.
40. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, Oberkanins C, Moritx A, Krugluger W, Huber J, Hopmeier P: Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49:1081-1086.
41. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P: Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians Haematologists (NOHA) study. Thromb Haemost 1997; 77:1096-1103.
42. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers CH, Eskes TK: Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998; 128:1336-1341.
43. Kutteh WH, Park VM, Deitcher SR: Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71:1048-1053.
44. Coumans AB, Huijgens PC, Jakobs C, Schats R, de Vries JI, van Pampus MG, Dekker GA: Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod 1999; 14:211-214.
45. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58:35-41.
46. Hasbargen U, Lohse P, Thaler CJ: The number of dichorionic twin pregnancies is reduced by the common MTHFR 677C>T mutation. Hum Reprod 2000; 15:2659-2662.
47. Dahlenback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of cofactor to protein C. Proc Natl Acad Sci U S A 1993; 90:1004-1008.